A large epidemiological study conducted in France shows that COVID-19 vaccines have not caused an increase in overall ...
Vinay Prasad’s memo makes alarming claims about the COVID-19 vaccine — including the assertion, made without any supporting ...
As of the November 30, 2025 data cutoff, two patients with non-Hodgkin’s lymphoma had completed multiple GT801 administrations without lymphodepleting chemotherapy, demonstrating the feasibility of ...
To accurately gauge a vaccine’s risks, it is also crucial to compare its side effects with the effects of the illness it ...
Vaccinated adults had a 74 percent lower risk of dying from COVID-19—and a 25 percent lower risk of dying, period.
Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...
Are things finally looking up for Merck (NYSE: MRK)? After being mostly southbound for the better part of the last two years, ...
StockStory.org on MSN
Why is Moderna (MRNA) stock rocketing higher today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major ...
The industry’s mRNA alliance is demanding steady FDA leadership, warning that the current “unprecedented turmoil” at the ...
Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...
Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback